{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:34:57Z","timestamp":1783658097647,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1012216","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000}}],"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206194\/Z\/17\/Z"],"award-info":[{"award-number":["206194\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI124678, R01 AI185559 and R01 AI109023"],"award-info":[{"award-number":["R01 AI124678, R01 AI185559 and R01 AI109023"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-033538"],"award-info":[{"award-number":["INV-033538"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014332","name":"Life Sciences Research Network Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>The human pathogens <jats:italic>Plasmodium<\/jats:italic> and <jats:italic>Schistosoma<\/jats:italic> are each responsible for over 200 million infections annually, especially in low- and middle-income countries. There is a pressing need for new drug targets for these diseases, driven by emergence of drug-resistance in <jats:italic>Plasmodium<\/jats:italic> and an overall dearth of drug targets against <jats:italic>Schistosoma<\/jats:italic>. Here, we explored the opportunity for pathogen-hopping by evaluating a series of quinoxaline-based anti-schistosomal compounds for their activity against <jats:italic>P. falciparum<\/jats:italic>. We identified compounds with low nanomolar potency against 3D7 and multidrug-resistant strains. <jats:italic>In vitro<\/jats:italic> resistance selections using wildtype and mutator <jats:italic>P. falciparum<\/jats:italic> lines revealed a low propensity for resistance. Only one of the series, compound <jats:bold>22<\/jats:bold>, yielded resistance mutations, including point mutations in a non-essential putative hydrolase <jats:italic>pfqrp1,<\/jats:italic> as well as copy number amplification of a phospholipid-translocating ATPase, <jats:italic>pfatp2<\/jats:italic>, a potential target. Notably, independently generated CRISPR-edited mutants in <jats:italic>pfqrp1<\/jats:italic> also showed resistance to compound <jats:bold>22<\/jats:bold> and a related analogue. Moreover, previous lines with <jats:italic>pfatp2<\/jats:italic> copy number variations were similarly less susceptible to challenge with the new compounds. Finally, we examined whether the predicted hydrolase activity of PfQRP1 underlies its mechanism of resistance, showing that both mutation of the putative catalytic triad and a more severe loss of function mutation elicited resistance. Collectively, we describe a compound series with potent activity against two important pathogens and their potential target in <jats:italic>P. falciparum<\/jats:italic>.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012216","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T18:47:12Z","timestamp":1738608432000},"page":"e1012216","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activity"],"prefix":"10.1371","volume":"21","author":[{"given":"Mukul","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Padalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edem","family":"Adika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Okombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-0915","authenticated-orcid":true,"given":"Marcus C. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"ppat.1012216.ref001","author":"WHO","year":"2024."},{"issue":"9","key":"ppat.1012216.ref002","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"PJ Rosenthal","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ppat.1012216.ref003","doi-asserted-by":"crossref","first-page":"e0010924","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"NJ White","year":"2024","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"ppat.1012216.ref004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"JN Burrows","year":"2017","journal-title":"Malar J"},{"issue":"3","key":"ppat.1012216.ref005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","article-title":"Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery","volume":"4","author":"MR Luth","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"8","key":"ppat.1012216.ref006","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","article-title":"Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"M Duffey","year":"2021","journal-title":"Trends Parasitol"},{"key":"ppat.1012216.ref007","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ejmech.2014.06.058","article-title":"Quinoxaline, its derivatives and applications: a state of the art review","volume":"97","author":"JA Pereira","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"7479","key":"ppat.1012216.ref008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"CW McNamara","year":"2013","journal-title":"Nature"},{"issue":"1","key":"ppat.1012216.ref009","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/s41467-023-38774-1","article-title":"Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum","volume":"14","author":"K K\u00fcmpornsin","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1012216.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00365-0","article-title":"Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and beta-hematin","volume":"113","author":"MM Chen","year":"2001","journal-title":"Mol Biochem Parasitol"},{"issue":"6","key":"ppat.1012216.ref011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/acsinfecdis.6b00205","article-title":"Antischistosomal activity of Pyrido[1,2-a]benzimidazole derivatives and correlation with inhibition of \u03b2-hematin formation","volume":"3","author":"J Okombo","year":"2017","journal-title":"ACS Infect Dis"},{"issue":"2","key":"ppat.1012216.ref012","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpddr.2017.03.007","article-title":"Novel carbazole aminoalcohols as inhibitors of \u03b2-hematin formation: Antiplasmodial and antischistosomal activities","volume":"7","author":"W Wang","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ppat.1012216.ref013","doi-asserted-by":"crossref","first-page":"113823","DOI":"10.1016\/j.ejmech.2021.113823","article-title":"Anti-schistosomal activities of quinoxaline-containing compounds: from hit identification to lead optimisation","volume":"226","author":"G Padalino","year":"2021","journal-title":"Eur J Med Chem"},{"key":"ppat.1012216.ref014","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12936-015-0962-2","article-title":"Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay","volume":"14","author":"M Linares","year":"2015","journal-title":"Malar J"},{"issue":"1\u20133","key":"ppat.1012216.ref015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"ppat.1012216.ref016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","article-title":"A drug-likeness toolbox facilitates ADMET study in drug discovery","volume":"25","author":"C-Y Jia","year":"2020","journal-title":"Drug Discov Today"},{"key":"ppat.1012216.ref017","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"ppat.1012216.ref018","first-page":"656","article-title":"In vitro and in silico assessment of antiproliferative activity of new acetamides bearing 1,3,4-oxadiazole and pyrimidine cores via COX inhibition","volume":"24","author":"B Sever","year":"2020","journal-title":"J Res Pharm"},{"key":"ppat.1012216.ref019","first-page":"123","article-title":"Plasmodium falciparum in vitro drug resistance selections and gene editing","author":"CL Ng","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"9","key":"ppat.1012216.ref020","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission","volume":"58","author":"KL Kuhen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6372","key":"ppat.1012216.ref021","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics","volume":"359","author":"AN Cowell","year":"2018","journal-title":"Science"},{"issue":"6388","key":"ppat.1012216.ref022","doi-asserted-by":"crossref","first-page":"eaap7847","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"M Zhang","year":"2018","journal-title":"Science"},{"issue":"3","key":"ppat.1012216.ref023","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/138620710790980496","article-title":"Lipophilic mediated assays for beta-hematin inhibitors","volume":"13","author":"MD Carter","year":"2010","journal-title":"Comb Chem High Throughput Screen"},{"key":"ppat.1012216.ref024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12936-015-0729-9","article-title":"Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials","volume":"14","author":"JM Combrinck","year":"2015","journal-title":"Malar J"},{"key":"ppat.1012216.ref025","doi-asserted-by":"crossref","first-page":"14240","DOI":"10.1038\/ncomms14240","article-title":"Esterase mutation is a mechanism of resistance to antimalarial compounds","volume":"8","author":"ES Istvan","year":"2017","journal-title":"Nat Commun"},{"key":"ppat.1012216.ref026","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphys.2016.00275","article-title":"P4-ATPases as phospholipid flippases-structure, function, and enigmas","volume":"7","author":"JP Andersen","year":"2016","journal-title":"Front Physiol"},{"key":"ppat.1012216.ref027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2019.02.004","article-title":"Phospholipid flippases in membrane remodeling and transport carrier biogenesis","volume":"59","author":"JT Best","year":"2019","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"ppat.1012216.ref028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/ETLS20220089","article-title":"The enemy within: lipid asymmetry in intracellular parasite-host interactions","volume":"7","author":"M Fraser","year":"2023","journal-title":"Emerg Top Life Sci"},{"issue":"2","key":"ppat.1012216.ref029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cell.2017.06.030","article-title":"Functional profiling of a Plasmodium genome reveals an abundance of essential genes","volume":"170","author":"E Bushell","year":"2017","journal-title":"Cell"},{"key":"ppat.1012216.ref030","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1038\/ncomms10519","article-title":"Functional profiles of orphan membrane transporters in the life cycle of the malaria parasite","volume":"7","author":"S Kenthirapalan","year":"2016","journal-title":"Nat Commun"},{"key":"ppat.1012216.ref031","article-title":"PfATP2 is an essential flippase on the Plasmodium falciparum surface that influences parasite sensitivity to antiplasmodial compounds","author":"D Qiu","year":"2024","journal-title":"bioRxiv"},{"issue":"4","key":"ppat.1012216.ref032","doi-asserted-by":"crossref","first-page":"e0163522","DOI":"10.1128\/mbio.01635-22","article-title":"CDC50 Orthologues in Plasmodium falciparum have distinct roles in merozoite egress and trophozoite maturation","volume":"13","author":"A Patel","year":"2022","journal-title":"mBio"},{"issue":"5996","key":"ppat.1012216.ref033","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"M Rottmann","year":"2010","journal-title":"Science"},{"issue":"10","key":"ppat.1012216.ref034","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciab716","article-title":"Efficacy of Cipargamin (KAE609) in a randomized, phase ii dose-escalation study in adults in Sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria","volume":"74","author":"EK Schmitt","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ppat.1012216.ref035","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2019.10.030","article-title":"Genome-Scale identification of essential metabolic processes for targeting the Plasmodium liver stage","volume":"179","author":"RR Stanway","year":"2019","journal-title":"Cell"},{"issue":"6061","key":"ppat.1012216.ref036","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"S Meister","year":"2011","journal-title":"Science"},{"issue":"1","key":"ppat.1012216.ref037","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1038\/s41467-024-49491-8","article-title":"Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1","volume":"15","author":"MG Dans","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1012216.ref038","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1371\/journal.pntd.0002610","article-title":"Orally active antischistosomal early leads identified from the open access malaria box","volume":"8","author":"K Ingram-Sieber","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ppat.1012216.ref039","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1550-7408.1983.tb02932.x","article-title":"Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients","volume":"30","author":"EM Rivadeneira","year":"1983","journal-title":"J Protozool"},{"key":"ppat.1012216.ref040","doi-asserted-by":"crossref","first-page":"e66277","DOI":"10.7554\/eLife.66277","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"BH Stokes","year":"2021","journal-title":"Elife"},{"issue":"4","key":"ppat.1012216.ref041","doi-asserted-by":"crossref","first-page":"e0154166","DOI":"10.1371\/journal.pone.0154166","article-title":"Evidence of a mild mutator phenotype in Cambodian Plasmodium falciparum malaria parasites","volume":"11","author":"AH Lee","year":"2016","journal-title":"PLoS ONE"},{"issue":"6220","key":"ppat.1012216.ref042","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"J Straimer","year":"2015","journal-title":"Science"},{"key":"ppat.1012216.ref043","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-0716-2189-9_17","article-title":"CRISPR\/Cas9 editing of the Plasmodium falciparum genome","author":"S Adjalley","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"2","key":"ppat.1012216.ref044","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chembiol.2019.11.009","article-title":"Combining stage specificity and metabolomic profiling to advance antimalarial drug discovery","volume":"27","author":"JM Murithi","year":"2020","journal-title":"Cell Chem Biol"},{"issue":"2","key":"ppat.1012216.ref045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"P Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"issue":"46","key":"ppat.1012216.ref046","first-page":"E1128","article-title":"Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion","volume":"108","author":"R Xi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ppat.1012216.ref047","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bbamem.2019.02.006","article-title":"Evolution and a revised nomenclature of P4 ATPases, a eukaryotic family of lipid flippases","author":"M Palmgren","year":"2019","journal-title":"Biochim Biophys Acta Biomembr"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1012216","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T18:49:31Z","timestamp":1739213371000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012216"}},"subtitle":[],"editor":[{"given":"Richard J.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012216","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1012216","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}